Navigating 4 Analyst Ratings For Bio-Techne
Navigating 4 Analyst Ratings For Bio-Techne
瀏覽 Bio-Techne 的 4 個分析師評級
In the preceding three months, 4 analysts have released ratings for Bio-Techne (NASDAQ:TECH), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有4位分析師發佈了Bio-Techne（納斯達克股票代碼：TECH）的評級，提出了從看漲到看跌的各種觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $77.25, along with a high estimate of $87.00 and a low estimate of $65.00. Experiencing a 11.54% decline, the current average is now lower than the previous average price target of $87.33.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲77.25美元，最高估計爲87.00美元，低估值爲65.00美元。目前的平均價格下降了11.54％，現在低於之前的平均目標股價87.33美元。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
A comprehensive examination of how financial experts...
對金融專家如何...
登入免費觀看全文
登入/註冊